Skip to main content

A MULTI-PART, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE 2 CLINICAL STUDY OF THE SAFETY AND EFFICACY OF CGT9486 IN SUBJECTS WITH NONADVANCED SYSTEMIC MASTOCYTOSIS

Open
  • Protocol code: CGT9486-21-202
  • EudraCT code: No aplica
  • Research group: Systemic Diseases
  • Service: Internal Medicine
  • Principal investigator:  Guilarte Clavero, Mar
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Phase: Fase II
  • Status: Recruiting volunteers